Tubulis Appoints Christian Grøndahl as Independent Chairman to Lead Supervisory Board


MUNICH, GERMANY, May 11, 2021 – Tubulis today announced the appointment of Dr. Christian Grøndahl, as the inaugural Chairman of the company’s Supervisory Board. As an experienced biotech executive and company founder, Dr. Grøndahl has an established track record in advancing early-stage biotech innovations and distinguished technology platforms into valuable products and medicines. His leadership will be fundamental to shaping Tubulis as it designs and moves its novel antibody-drug conjugates (ADCs) toward clinical evaluation to improve cancer treatments and further establishes itself as an up-and-coming leader in the oncology and ADC drug development field.